130 related articles for article (PubMed ID: 937182)
1. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.
Meyer SL; Curry GC; Donsky MS; Twieg DB; Parkey RW; Willerson JT
Am J Cardiol; 1976 Jul; 38(1):103-8. PubMed ID: 937182
[TBL] [Abstract][Full Text] [Related]
2. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.
Willerson JT; Hutton I; Watson JT; Platt MR; Templeton GH
Circulation; 1976 May; 53(5):828-33. PubMed ID: 1260986
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of dobutamine in patients with coronary artery disease.
Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
[TBL] [Abstract][Full Text] [Related]
4. Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
Bendersky R; Chatterjee K; Parmley WW; Brundage BH; Ports TA
Am J Cardiol; 1981 Sep; 48(3):554-8. PubMed ID: 7270460
[TBL] [Abstract][Full Text] [Related]
5. [The value of dobutamine in cardiology].
Baudet M; Rigaud M; Bardet J; Bourdarias JP
Ann Anesthesiol Fr; 1978; 19(10):863-8. PubMed ID: 35060
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease.
Pacold I; Kleinman B; Gunnar R; Loeb HS
Circulation; 1983 Nov; 68(5):1044-50. PubMed ID: 6616788
[TBL] [Abstract][Full Text] [Related]
7. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
Fowler MB; Alderman EL; Oesterle SN; Derby G; Daughters GT; Stinson EB; Ingels NB; Mitchell RS; Miller DC
Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
[TBL] [Abstract][Full Text] [Related]
8. Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine.
Schulz R; Miyazaki S; Miller M; Thaulow E; Heusch G; Ross J; Guth BD
Circ Res; 1989 Jun; 64(6):1116-26. PubMed ID: 2720914
[TBL] [Abstract][Full Text] [Related]
9. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
Loeb HS; Bredakis J; Gunner RM
Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
[TBL] [Abstract][Full Text] [Related]
10. Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium.
Wynsen JC; O'Brien PD; Warltier DC
J Am Coll Cardiol; 1994 Jan; 23(1):233-41. PubMed ID: 8277087
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular effects of dobutamine (author's transl)].
Limbourg P; Just H; Kersting F; Lang KF
Klin Wochenschr; 1978 Jun; 56(11):551-7. PubMed ID: 661150
[No Abstract] [Full Text] [Related]
12. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
Fleck E; Dirschinger J; Rudolph W
Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
[No Abstract] [Full Text] [Related]
13. Influence of hypertonic mannitol on ventricular performance and coronary blood flow in patients.
Willerson JT; Curry GC; Atkins JM; Parkey R; Horwitz LD
Circulation; 1975 Jun; 51(6):1095-100. PubMed ID: 1132099
[TBL] [Abstract][Full Text] [Related]
14. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
Magorien RD; Unverferth DV; Brown GP; Leier CV
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):499-505. PubMed ID: 6826960
[TBL] [Abstract][Full Text] [Related]
15. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
Jewitt D; Birkhead J; Mitchell A; Dollery C
Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
[No Abstract] [Full Text] [Related]
16. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
Hess W; Brückner JB; Schmidt D; Schweichel E; Tarnow J
Z Kardiol; 1977 Oct; 66(10):537-44. PubMed ID: 919662
[TBL] [Abstract][Full Text] [Related]
17. Drugs five years later. Dobutamine.
Leier CV; Unverferth DV
Ann Intern Med; 1983 Oct; 99(4):490-6. PubMed ID: 6625384
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the hemodynamic effects induced by dobutamine, isoproterenol and dopamine in patients with coronary artery disease (author's transl)].
Ambrosioni E; Maresta A; Magnani B
G Ital Cardiol; 1979; 9(7):708-14. PubMed ID: 540702
[TBL] [Abstract][Full Text] [Related]
19. The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.
Tuttle RR; Pollock GD; Todd G; MacDonald B; Tust R; Dusenberry W
Circ Res; 1977 Sep; 41(3):357-64. PubMed ID: 890890
[No Abstract] [Full Text] [Related]
20. [Hemodynamic evaluation of the action of calcium antagonists].
Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
